Powszechny Zaklad Ubezpieczen (STU:7PZ) Research & Development: €0 Mil (TTM As of Mar. 2026)


STU:7PZ Powszechny Zaklad Ubezpieczen SA STU:7PZ
87 GF Score
Price €15.25
GF Value €13.99
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Powszechny Zaklad Ubezpieczen Research & Development?

Powszechny Zaklad Ubezpieczen STU:7PZ +0.76% 87 Research & Development is €0 Mil as of Mar. 2026. GuruFocus rates STU:7PZ with a GF Score™ of 87/100 and a GF Value™ of €13.99 (Fairly Valued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Powszechny Zaklad Ubezpieczen's Research & Development for the three months ended in Mar. 2026 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was €0 Mil.

Powszechny Zaklad Ubezpieczen  (STU:7PZ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Powszechny Zaklad Ubezpieczen Research & Development Related Terms

Powszechny Zaklad Ubezpieczen Research & Development Historical Data

* Premium members only.

The historical data trend for Powszechny Zaklad Ubezpieczen's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Powszechny Zaklad Ubezpieczen Research & Development Chart

Powszechny Zaklad Ubezpieczen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Powszechny Zaklad Ubezpieczen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STU:7PZ
87GF Score
Powszechny Zaklad Ubezpieczen SA STU:7PZ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Powszechny Zaklad Ubezpieczen Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Powszechny Zaklad Ubezpieczen (STU:7PZ) has a Research & Development of €0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Powszechny Zaklad Ubezpieczen and its competitors.
Is Powszechny Zaklad Ubezpieczen's Research & Development too high?
Powszechny Zaklad Ubezpieczen's current Research & Development is €0 Mil. Overall, Powszechny Zaklad Ubezpieczen has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Powszechny Zaklad Ubezpieczen's Research & Development compare to CB and PGR?
Powszechny Zaklad Ubezpieczen's Research & Development of €0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Powszechny Zaklad Ubezpieczen and its competitors. Powszechny Zaklad Ubezpieczen's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Powszechny Zaklad Ubezpieczen stock overvalued right now?
Based on GuruFocus' analysis, Powszechny Zaklad Ubezpieczen (STU:7PZ) is currently considered Fairly Valued. The stock's GF Value™ is €13.99, compared to a current price of €15.25 — trading 9% above its estimated fair value. The current Research & Development is €0 Mil. Powszechny Zaklad Ubezpieczen's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Powszechny Zaklad Ubezpieczen (STU:7PZ), the current Research & Development is €0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Powszechny Zaklad Ubezpieczen (STU:7PZ) Overvalued in 2026?

Based on GuruFocus' analysis, Powszechny Zaklad Ubezpieczen stock appears to be overvalued. The current stock price of €15.25 is trading 9% above its estimated GF Value™ of €13.99. GuruFocus considers Powszechny Zaklad Ubezpieczen to be Fairly Valued.

Key valuation signals for STU:7PZ:

  • Research & Development: €0 Mil
  • GF Value™: €13.99 vs. price of €15.25 (9% above fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the STU:7PZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Powszechny Zaklad Ubezpieczen Business Description

Other Exchanges PZAKY:USAPZU:Poland
Address Al. Jana Pawla II 24, Warsaw, POL, 00-133
Powszechny Zaklad Ubezpieczen SA is a property and casualty insurance company that operates in the Central and Eastern European region with an emphasis on the Polish market. The company's main strategic objectives include stable financial results, broad growth, and innovation. The vast majority of Powszechny's revenue is generated from gross written premiums, followed by results of its investment activities. The company serves clients through its own agency network along with sales through external agency centers.
87GF Score

Get the complete analysis for STU:7PZ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.25
Price
€13.99
GF Value